Connect your AI

Harrow HROW Non-Controlling Interests

Non-Controlling Interests at other companies

Bausch + LombBLCO

$73M+1.4%

Bausch Health CompaniesBHC

$977M+3.6%

BrightSpring Health Services, Inc.BTSG

$63K+150%

UnitedHealth GroupUNH

$6.01B+4.2%

Other financials

Income statement

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

Cash & equivalents$94.6M+41.8%

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

Market cap$1.59B+38.4%

Enterprise value$1.8B+13.8%

P/S5.9×+0.5×

Profitability

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Harrow's non-controlling interests?: Harrow (HROW) reported non-controlling interests of -$355K in Q1 2026.
How has Harrow's non-controlling interests changed year-over-year?: Harrow's non-controlling interests decreased by 0.0% year-over-year, from -$355K to -$355K.
What is the long-term trend for Harrow's non-controlling interests?: Over 5 years (2020 to 2025), Harrow's non-controlling interests has grown at a 0.0% compound annual growth rate (CAGR), from -$355K to -$355K.
What does non-controlling interests mean?: Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.